NDC 58160-955

Menveo

Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine

Menveo is a Kit in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is .

• Product ID: 58160-955_0a4aada2-4582-4bf2-a27e-6e46874c1c5a
• NDC: 58160-955
• Product Type: Vaccine
• Proprietary Name: Menveo
• Generic Name: Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine
• Dosage Form: Kit
• Marketing Start Date: 2017-03-01
• Marketing Category: BLA / BLA
• Application Number: BLA125300
• Labeler Name: GlaxoSmithKline Biologicals SA
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 58160-955-09

1 KIT in 1 CARTON (58160-955-09) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-958-01) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-959-01)

• Marketing Start Date: 2017-03-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 58160-955-09 [58160095509]

Menveo KIT

• Marketing Category: BLA
• Application Number: BLA125300
• Product Type: VACCINE
• Billing Unit: EA
• Marketing Start Date: 2017-03-01

Drug Details

NDC Crossover Matching brand name "Menveo" or generic name "Meningococcal (groups A, C, Y And W-135) Oligosaccharide Diphtheria Crm197 Conjugate Vaccine"

NDC	Brand Name	Generic Name
58160-827	Menveo	Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine
58160-955	Menveo	Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine